Management of hepatic encephalopathy: focus on antibiotic therapy.
about
Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory.Rifaximin for treatment of hepatic encephalopathy.Pharmacotherapy of hepatic encephalopathy in cirrhosis.Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats.L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.
P2860
Management of hepatic encephalopathy: focus on antibiotic therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Management of hepatic encephalopathy: focus on antibiotic therapy.
@ast
Management of hepatic encephalopathy: focus on antibiotic therapy.
@en
type
label
Management of hepatic encephalopathy: focus on antibiotic therapy.
@ast
Management of hepatic encephalopathy: focus on antibiotic therapy.
@en
prefLabel
Management of hepatic encephalopathy: focus on antibiotic therapy.
@ast
Management of hepatic encephalopathy: focus on antibiotic therapy.
@en
P2093
P2860
P356
P1433
P1476
Management of hepatic encephalopathy: focus on antibiotic therapy.
@en
P2093
Amanda Vestito
Antonio Colecchia
Enrico Roda
P2860
P304
P356
10.1159/000089784
P478
73 Suppl 1
P577
2006-02-08T00:00:00Z